Search
for
Sort by
Research 361–390 of 1000+
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Modifiable Lifestyle and Behavioral Factors Associated With Disease Severity in Androgenetic Alopecia: A Propensity Score–Matched Cross‐Sectional Study
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- FUE, Sapphire FUE, DHI, and FUT Graft Survival by Norwood Stage and Donor Difficulty (Hair Type): A Retrospective Cohort Study at Vera Clinic
- Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
- Highly Prevalent LIPH Founder Mutations Causing Autosomal Recessive Woolly Hair/Hypotrichosis in Japan and the Genotype/Phenotype Correlations
- Serum Vitamin D Levels and Severity of Male Androgenetic Alopecia in North Sulawesi: A Cross-Sectional Study
- Deficiency Pattern and Responsiveness in Clinical Settings in Discovering the Correlation between Vitamin D Analogues and Hair Growth in Alopecia Areata
- Association Between Scalp Microbiota Imbalance, Disease Severity, and Systemic Inflammatory Markers in Alopecia Areata
- Association Between Smoking and Androgenetic Alopecia: A Cross-Sectional Analysis of Severity and Dose-Response Relationship in Adult Males
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- A population-based study on the common androgenic symptoms in PCOS and its management
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery
- LO-009 Responsiveness of the CLASI to alopecia and mucous membrane involvement: a retrospective study of prospectively collected data
- Signposts to the Promised Land in Alopecia Areata
- The efficacy of an adjuvant norethisterone (jenapharm) therapy in endometrial cancer
- Multiple courses of pulse corticosteroid therapy for alopecia areata
- Group Treatment for Trichotillomania: Behavior Therapy Versus Supportive Therapy
- Reply to comment on: The Gabrin sign
- A randomised open label comparative study of hydroxychloroquine with betamethasone oral minipulse in the management of patients with alopecia areata.
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Pathological sequelae of long-haul COVID
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Androgenic Alopecia and Stress-Induced Premature Senescence by Cumulative Ultraviolet Light Exposure
- Long COVID syndrome: An unfolding enigma
- Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study